Histamine, mast cells and tumour cell proliferation in breast cancer: Does preoperative cimetidine administration have an effect?

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 167-170

  Bowrey, P F ^a   King, J ^a   Magarey, C ^a   Schwartz, P ^a   Marr, P ^a   Bolton, E ^a   Morris, D L ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Histamine; Ki 67; Mast cell; Proliferation index

Indexed keywords

CIMETIDINE; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MAST CELL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

EID: 0033989894     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0895     Document Type: Article

References (22)

1. Aaltomaa S. Lipponen P, Papinaho S and Kosma V-M (1993) Mast cells in breast cancer. Anticancer Res 13: 785-788
2. Adams WJ and Morris DL (1997) Pilot study - cimetidine enhances lymphocyte infiltration of human colorectal carcinoma. Cancer 80: 15-21
3. Adams WJ, Lawson JA and Morris DL (1994) Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35: 1632-1636
4. Bouzuhar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JFR, Blamey RW and Nicholson RI (1989) Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59: 943-947
5. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J and Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363
6. Cricco GP, Davio CA, Martin G, Engel N, Fitzsimons CP, Bergoc RM and Rivera ES (1994) Histamine as an autocrine growth factor in experimental mammary carcinomas. Agents Actions 43: 17-20
7. Davio CA, Cricco GP, Martin G, Fitzsimons CP, Bergoc RM and Rivera ES (1994) Effect of histamine on growth and differentiation of the rat mammary gland. Agents Actions 41 Special conference Issue: C115-C117
8. Davio C, Baldi A, Mladovan A, Cricco G, Fitzsimons C, Bergoc R and Rivera E (1995) Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas. Inflamm Res 44: S70-S71
9. Ferno M (1998) Prognostic factors in breast cancer: a brief review. Anticancer Res 18: 2167-2172
10. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E and Flad H-D (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138: 867-873
11. Lemos B, Davio C, Gass H, Gonzalez P, Cricco G, Martin G, Bergoc R and Rivera E (1995) Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas. Inflamm Res 44: S68-S69
12. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P and Barbareschi M (1992) PCNA and Ki67 expression in breast carcinomas: correlations with clinical and biological variables. J Clin Pathol 45: 416-419
13. McCormick D, Yu C, Hobbs C and Hall PA (1993) The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 22: 543-547
14. Ng WK, Vonthethoff LW, Magarey CJ, Adams WJ and Morris DL (1995) The effect of histamine antagonists on the presence of tumour infiltrating lymphocytes in breast cancer: a retrospective study. Surg Res Comm 18: 69-74
15. Railo M, Nordling S, von Boguslawsky K, Leivonen M Kyllonen L and von Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68: 579-583
16. Railo M, Lundin J, Haglund C, von Smitten K, von Boguslawsky K and Nordling S (1997) Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer. Acta Oncologica 36: 369-374
17. Reynolds JL, Akhter JA, Magarey CJ, Schwartz P, Adams WJ and Morris DL (1998) Histamine in human breast cancer 8. Br J Surg 85: 538-541
18. Schauer A, Korabiowska M, Kellner S, Schumacher M, Sauer R, Bojar H and Rauschecker H (1998) Grading system for breast cancer. Anticancer Res 18: 2139-2144
19. Thomas M, Noguchi M, Kitagawa H, Kinoshila K and Miyazaki I (1993) Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma. J Clin Pathol 46: 525-528
20. Tubiana M and Courdi A (1989) Cell proliferation kinetics in human solid tumours: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 15: 1-18
21. Veronese SM and Gambacorta M (1991) Detection of Ki-67 proliferation rate in breast cancer: correlation with clinical and pathological features. Ant J Clin Pathol 95: 30-34
22. Vielh P, Chevillard S, Mosseri V, Donatini B and Magdelenat H (1990) Ki67 index and S-phase fraction in human breast carcinomas: comparison and correlations with prognostic factors. Am J Clin Pathol 94: 681-686